Scientists track experimental Drug's journey through the body
NCT ID NCT04634812
Summary
This early-stage study aimed to understand how the body absorbs, breaks down, and eliminates the experimental drug KBP-5074. Seven healthy male volunteers received a single dose containing a tiny, safe amount of radioactive tracer to help track the drug. Researchers measured how much drug was absorbed, how long it stayed in the body, and what byproducts were created when the body processed it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.